Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion

Abstract

Recent evidence suggests that host immune cells contribute to the development of malignant pleural effusion (MPE), a common manifestation of metastatic cancer. We have identified such cells, predominantly mononuclear myeloid cells, recruited by tumor-orchestrated inflammatory chemokines. Moreover, targeting of these inflammation-associated mediators modified the disease course of MPE in mice. © 2014 Landes Bioscience.